Linkage of Rapid Estrogen Action to MAPK Activation by ER #945 -Shc


PDF
List Docs
PDF Novel Mechanisms of Estrogen Action in the Brain

Estrogen elicits a selective enhancement of the growth and differentiation of axons and dendrites (neurites) in the developing brain

  • How does estrogen act as a transcription factor?

    Estrogen receptors (ERs) act by regulating transcriptional processes.
    The classical mechanism of ER action involves estrogen binding to receptors in the nucleus, after which the receptors dimerize and bind to specific response elements known as estrogen response elements (EREs) located in the promoters of target genes.

  • What does estrogen bind to?

    As a steroid hormone, estrogen can enter the plasma membrane and interact with intracellular ERα and ERβ to exert direct effects by binding to DNA sequences.
    Alternatively, estrogen can activate intracellular signaling cascades via interaction with the GPER1 and/or ERα and ERβ.

  • What does the ESR1 gene do?

    hepatic Estradiol/ESR1 signaling plays a key role in the maintenance of gluconeogenesis and lipid metabolism in males.
    ESR1 inhibits chorionic gonadotropin-induced steroidogenesis and proliferation of progenitor Leydig cells in mice.
    High ESR1 expression is associated with metastasis in breast Cancer.

  • What happens when estrogen binds to its receptor?

    The binding of estrogen to the ER results in a series of downstream steps that modulate transcription of genes responsible for cellular function, tumor growth, invasion, angiogenesis, and survival.
    Endocrine therapy either antagonizes the ER or causes estrogen deprivation.

  • What is the mechanism of estrogen signaling?

    As a steroid hormone, estrogen can enter the plasma membrane and interact with intracellular ERα and ERβ to exert direct effects by binding to DNA sequences.
    Alternatively, estrogen can activate intracellular signaling cascades via interaction with the GPER1 and/or ERα and ERβ.

  • What is the signaling pathway of estrogen?

    Estrogen mediates its cellular actions through two signaling pathways classified as "nuclear-initiated steroid signaling" and "membrane-initiated steroid signaling".

  • hepatic Estradiol/ESR1 signaling plays a key role in the maintenance of gluconeogenesis and lipid metabolism in males.
    ESR1 inhibits chorionic gonadotropin-induced steroidogenesis and proliferation of progenitor Leydig cells in mice.
    High ESR1 expression is associated with metastasis in breast Cancer.

  • Proposed primary target cells for estrogens in bone include growth plate chondrocytes, endosteal and trabecular lining cells/osteoblasts, osteocytes, mesenchymal cells in the bone marrow, osteoclasts, B and T lymphocytes, and megakaryocytes (6, 12–19).

    • Does ER play a role in MAPK activation?

      ERα-dependent MAPK activation has been reported by many laboratories using MCF-7 and other cell lines treated with E2 ( 39, 43 ). The differences regarding ERα involvement in MAPK activation under varying conditions are unknown.

    • Does estrogen stimulate mitogen-activated protein kinase in rat hippocampus?

      Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-α knock-out mice. Putative membrane-bound estrogen receptors possibly stimulate mitogen-activated protein kinase in the rat hippocampus.

    • How does E2 affect MAPK activation?

      Together, our data suggest that the nongenomic effects of E2 on Shc and MAPK activation are mediated by the classical ERα receptor, that E2 can induce an association of ERα with Shc, and that Shc appears to be a crucial step for the activation of MAPK.

    • How does oestradiol and progestin activate ERK-1 and erk-2?

      Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. Constitutive phosphorylation of Shc proteins in human tumors.

    However, the rapid nongenomic actions of estrogens, which are linked to the PI3K/Akt and ERK/MAPK pathways, are critical in this process. The corresponding pharmacological inhibitors of the PI3K/Akt or ERK/MAPK pathways block the effect of estrogens on NPY gene expression. E2 rapidly activates MAPK in breast cancer cells, and the mechanism for this effect has not been fully identified. Since growth factor-induced MAPK  Autres questions
    Share on Facebook Share on Whatsapp











    Choose PDF
    More..












    Tutoriel pour la création d 'un site web - Google Sites - Challenge Fly Google Sites Le nouveau Google Sites Travailler partout Simplicité d 'utilisation Dictionnaire Swahili-Français - CongoForum Livre blanc sur la confidentialité dans Google Chrome RÈGLEMENT DU CONCOURS « TOI-MÊME TU FILMES » 1 manuel de l 'utilisateur - GoPro manuel de l 'utilisateur - GoPro

    PDFprof.com Search Engine
    Images may be subject to copyright Report CopyRight Claim

    PDF] Linkage of rapid estrogen action to MAPK activation by

    PDF] Linkage of rapid estrogen action to MAPK activation by


    PDF] Linkage of rapid estrogen action to MAPK activation by

    PDF] Linkage of rapid estrogen action to MAPK activation by


    PDF] Rapid extranuclear signaling by the estrogen receptor (ER

    PDF] Rapid extranuclear signaling by the estrogen receptor (ER


    PDF] Linkage of rapid estrogen action to MAPK activation by

    PDF] Linkage of rapid estrogen action to MAPK activation by


    PDF] Rapid extranuclear signaling by the estrogen receptor (ER

    PDF] Rapid extranuclear signaling by the estrogen receptor (ER


    PDF] Rapid extranuclear signaling by the estrogen receptor (ER

    PDF] Rapid extranuclear signaling by the estrogen receptor (ER


    PDF] Linkage of rapid estrogen action to MAPK activation by

    PDF] Linkage of rapid estrogen action to MAPK activation by


    IJMS

    IJMS


    p130Cas interacts with estrogen receptor α and modulates non

    p130Cas interacts with estrogen receptor α and modulates non


    Frontiers

    Frontiers


    Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin

    Estrogen Enhances Linkage in the Vascular Endothelial Calmodulin


    Steering estrogen signals from the plasma membrane to the nucleus

    Steering estrogen signals from the plasma membrane to the nucleus


    Activation of the p38 Mitogen-activated Protein Kinase Pathway by

    Activation of the p38 Mitogen-activated Protein Kinase Pathway by


    Cells

    Cells


    PDF) Extranuclear Steroid Receptors: Nature and Actions

    PDF) Extranuclear Steroid Receptors: Nature and Actions


    IJMS

    IJMS


    PDF) Mechanisms of Estrogen Receptor Signaling: Convergence of

    PDF) Mechanisms of Estrogen Receptor Signaling: Convergence of


    Antioxidants

    Antioxidants


    Increases in estrogen receptor‐α concentration in breast cancer

    Increases in estrogen receptor‐α concentration in breast cancer


    Inhibitory effects of 17β-estradiol or a resveratrol dimer on

    Inhibitory effects of 17β-estradiol or a resveratrol dimer on


    PDF) Role of receptor complexes in the extranuclear actions of

    PDF) Role of receptor complexes in the extranuclear actions of


    IJMS

    IJMS


    Extranuclear signaling by sex steroid receptors and clinical

    Extranuclear signaling by sex steroid receptors and clinical


    Dynamic changes in binding interaction networks of sex steroids

    Dynamic changes in binding interaction networks of sex steroids


    Nonnuclear Actions of Estrogen

    Nonnuclear Actions of Estrogen


    The Role of 17β-Estradiol and Estrogen Receptors in Regulation of

    The Role of 17β-Estradiol and Estrogen Receptors in Regulation of


    Cells

    Cells


    Communication between genomic and non-genomic signaling events

    Communication between genomic and non-genomic signaling events


    Clinical Aspects of Estrogen and Progesterone Receptors and ERBB2

    Clinical Aspects of Estrogen and Progesterone Receptors and ERBB2


    Role of phospho–ezrin in differentiating thyroid carcinoma

    Role of phospho–ezrin in differentiating thyroid carcinoma


    PDF) Estrogen Dendrimer Conjugates that Preferentially Activate

    PDF) Estrogen Dendrimer Conjugates that Preferentially Activate


    Estrogen induces rapid translocation of estrogen receptor beta

    Estrogen induces rapid translocation of estrogen receptor beta


    PDF) Biphasic estradiol-induced AKT phosphorylation is modulated

    PDF) Biphasic estradiol-induced AKT phosphorylation is modulated


    Estrogen Regulates MAPK-Related Genes through Genomic and

    Estrogen Regulates MAPK-Related Genes through Genomic and


    ER-α36  a Novel Variant of ER-α  Mediates Estrogen-Stimulated

    ER-α36 a Novel Variant of ER-α Mediates Estrogen-Stimulated


    Clinical Aspects of Estrogen and Progesterone Receptors and ERBB2

    Clinical Aspects of Estrogen and Progesterone Receptors and ERBB2


    Signaling by estrogens - Cheskis - 2007 - Journal of Cellular

    Signaling by estrogens - Cheskis - 2007 - Journal of Cellular


    IJMS

    IJMS


    p130Cas interacts with estrogen receptor α and modulates non

    p130Cas interacts with estrogen receptor α and modulates non

    Politique de confidentialité -Privacy policy